CONTINUING EDUCATION:
RN, NP:  1 CE Credit, 1 Pharmacology

Recorded Date:  April 17, 2016 (as part of the 2016 PCNA Annual Symposium in Orlando)
Original Posting Date: September 12, 2016
Content Review Date: September 2017

AUDIENCE:
Nurses, advanced practice nurses, and other healthcare providers interested in the prevention and management of cardiovascular disease.

COST:
This online educational activity is offered free of charge.

PARTICIPATION IN THE ACTIVITY AND RECEIPT OF CERTIFICATE OF CREDIT:
View the course materials; complete the post-test (you can take the post-test more than once if needed to achieve a passing score of 75%) and online evaluation form at the end of the activity, and print your CE certificate.

ACCREDITOR:
This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is accredited by the American Association of Nurse Practitioners (AANP) as an approved provider of Nurse Practitioner continuing education, provider number 030602. 

Please note that if you received credit for attending the 2016 PCNA Annual Symposium in Orlando, you will be unable to claim credit for the on-demand sessions that were recorded there.  

Contrast the mechanism of action of statins and PCSK9s in lowering LDL cholesterol
Define the scope of the problem of statin intolerance
List the indication for use of PCSK9 inhibitors
Contrast the concepts of efficacy and clinical benefit